DF Dent & Co. Inc. lessened its stake in Exponent, Inc. (NASDAQ:EXPO) by 2.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 480,141 shares of the business services provider’s stock after selling 14,144 shares during the quarter. DF Dent & Co. Inc. owned about 1.86% of Exponent worth $27,992,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. SG Americas Securities LLC acquired a new stake in Exponent in the 2nd quarter valued at about $278,000. Gotham Asset Management LLC bought a new position in shares of Exponent in the 1st quarter valued at about $394,000. BlackRock Inc. boosted its stake in shares of Exponent by 41,234.4% in the 1st quarter. BlackRock Inc. now owns 3,080,242 shares of the business services provider’s stock valued at $183,428,000 after purchasing an additional 3,072,790 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of Exponent by 2.3% in the 2nd quarter. Principal Financial Group Inc. now owns 210,098 shares of the business services provider’s stock valued at $12,249,000 after purchasing an additional 4,794 shares during the last quarter. Finally, Vanguard Group Inc. boosted its stake in shares of Exponent by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 2,176,141 shares of the business services provider’s stock valued at $129,590,000 after purchasing an additional 81,811 shares during the last quarter. Hedge funds and other institutional investors own 88.26% of the company’s stock.
Shares of Exponent, Inc. (NASDAQ EXPO) traded down 0.60% on Tuesday, hitting $75.15. 17,372 shares of the stock traded hands. Exponent, Inc. has a 1-year low of $48.42 and a 1-year high of $76.20. The stock has a 50 day moving average of $70.51 and a 200-day moving average of $63.28. The stock has a market cap of $1.94 billion, a PE ratio of 38.96 and a beta of 0.61.
The company also recently disclosed a quarterly dividend, which was paid on Friday, September 22nd. Stockholders of record on Friday, September 1st were paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 1.11%. The ex-dividend date was Wednesday, August 30th. Exponent’s dividend payout ratio is currently 43.52%.
Several research analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Exponent from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 19th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $75.00 target price on shares of Exponent in a research note on Thursday, August 31st. ValuEngine raised shares of Exponent from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th. Finally, BidaskClub raised shares of Exponent from a “strong sell” rating to a “sell” rating in a research note on Wednesday, July 5th.
ILLEGAL ACTIVITY WARNING: This article was first published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.com-unik.info/2017/10/10/df-dent-co-inc-lowers-holdings-in-exponent-inc-expo.html.
In other news, insider Sally Shepard sold 1,255 shares of the company’s stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $65.37, for a total value of $82,039.35. Following the completion of the transaction, the insider now owns 1,560 shares of the company’s stock, valued at $101,977.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Harri Kytomaa sold 12,000 shares of the company’s stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $66.38, for a total value of $796,560.00. Following the completion of the transaction, the insider now directly owns 11,360 shares of the company’s stock, valued at approximately $754,076.80. The disclosure for this sale can be found here. Insiders sold 80,848 shares of company stock valued at $5,425,477 in the last ninety days. 2.80% of the stock is currently owned by insiders.
Exponent Company Profile
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO).
What are top analysts saying about Exponent Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Exponent Inc. and related companies.